Clinical Trials Directory

Trials / Completed

CompletedNCT03509740

Intravenous Tramadol Versus Intravenous Paracetamol in Patients With Dysmenorrhea

Efficacy and Safety of Intravenous Tramadol Versus Intravenous Paracetamol for Relief of Acute Pain of Primary Dysmenorrhea: A Randomized Controlled Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Cairo University · Academic / Other
Sex
Female
Age
18 Years – 35 Years
Healthy volunteers
Not accepted

Summary

Patients presented with primary dysmenorrhea composed the study population. One gram paracetamol and 100 mg tramadol in 100 ml saline with a slow infusion were compared in ceasing dysmenorrhea in the emergency department

Detailed description

Patients over 18 years old who presented with dysmenorrhea composed the study population. Patients received painkiller within the last six hours, physical findings consistent with peritoneal irritation, allergy to the study drugs, renal or liver failure, drug addiction, pregnancy or woman with lactation and denied to give inform consent were the exclusion criteria. The pain of the study patients is measured with the visual analogue scale at baseline, 15th and 30th minutes and 1 hour after study drug administration. At the end of the 60 minutes, rescue drug need is also recorded.

Conditions

Interventions

TypeNameDescription
DRUGtramadol100 mg tramadol in 100 ml saline with slow infusion
DRUGparacetamolIntravenous 1 gm paracetamol in 100 ml saline with slow infusion

Timeline

Start date
2018-04-25
Primary completion
2018-10-01
Completion
2018-10-20
First posted
2018-04-26
Last updated
2020-06-16

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03509740. Inclusion in this directory is not an endorsement.